| Description | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
| molecular weight | 603.55 |
| Molecular formula | C29H32F2N3O7P |
| CAS | 1258595-14-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | 1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended. |
| References | 1. Carole Bourquin, et al. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists. Pharmacological Research. 2019 Mar. 2. LHC165. |